Drug use disorders
|
Status:
|
In progress
|
|
Anticipated publication date:
|
December 2012
|
NICE Project Team
|
Associate Director:
|
Nick Baillie
|
|
Consultant Clinical Adviser:
|
Tim Stokes
|
|
Programme Manager:
|
Andrew Wragg
|
|
Lead Technical Analyst:
|
Nicola Greenway
|
|
Project Manager:
|
Esther Clifford
|
|
Co-ordinator:
|
Lucy Spiller
|
Topic Expert Group
Mr Nick Barton
Chief Executive, Action on Addiction
Dr Stephen Brinksman
GP, Substance Misuse Management in General Practice
Mr Pete Burkinshaw
Skills and Development Manager, The National Treatment Agency for Substance Misuse
Dr Ed Day
Consultant in Addiction Psychiatry, Birmingham & Solihull Mental Health NHS Foundation Trust
Ms Viv Evans
Lay member
Dr Emily Finch (Chair)
Clinical Director for Addiction, South London and Maudsley NHS Foundation Trust
Dr Andre Geel
Consultant Clinical Psychologist, Central and North West London NHS Foundation Trust
Miss Jood Gibbins
Clinical Recovery Manager, Winchester and Eastleigh Recovery Centres for Substance Misuse Services
Mr Paul Hawkins
Lay member
Mr John Jolly
Chief Executive, Blenheim CDP
Dr Luke Mitcheson
Consultant Clinical Psychologist, South London and Maudsley NHS Foundation Trust
Dr Sue Price
Lay member
Mr Kevin Ratcliffe
Consultant Pharmacist, Birmingham Drug and Alcohol Action Team
Project History
|
Consultation
The draft NICE quality standard for drug use disorders is now available for consultation. The consultation period will end at 5pm on 19 June 2012.
Consultation documents
Please note that this quality standard is provisional and may change after consultation with stakeholders and fieldwork.
Background documents
The following supporting documents were used in formulating the draft quality standard. These are working documents which are provided as background information only and are not for consultation.
- Drug use disorders briefing paper
- Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults: management in primary, secondary and community care. NICE clinical guideline 113 (2011; NHS Evidence accredited).
- Depression in adults: the treatment and management of depression in adults. NICE clinical guideline 90 (2009; NHS Evidence accredited).
- Needle and syringe programmes: providing people who inject drugs with injecting equipment. NICE public health guidance 18 (2009; NHS Evidence accredited).
- Drug misuse: opioid detoxification. NICE clinical guideline 52 (2007; NHS Evidence accredited).
- Drug misuse: psychosocial interventions. NICE clinical guideline 51 (2007; NHS Evidence accredited).
- Department of Health (England) and the devolved administrations (2007) Drug misuse and dependence: UK guidelines on clinical management
- Naltrexone for the management of opioid dependence. NICE technology appraisal guidance 115 (2007).
- Methadone and buprenorpine for the management of opioid dependence. NICE technology appraisal guidance 114 (2007).
- Minutes of drug use disorders Topic Expert Group meeting 1: Scoping Workshop
- Minutes of drug use disorders Topic Expert Group Meeting 2
- Equality analysis: scoping
- Equality analysis: consultation
How to submit your comments
Please provide all responses to the draft quality standard using the comments proforma (ensuring all relevant fields are completed, including your organisation's full name) and forward this electronically by 5pm on 19 June 2012 at the very latest to this email address: QSconsultations@nice.org.uk
The Institute is unable to accept
- Comments from non-registered organisations - if you wish your comments to be considered please register via the NICE website
- Comments from individuals - please contact the registered stakeholder organisation that most closely represents your interests and pass your comments to them.
- Comments received after the consultation deadline (5pm)
- Comments that are not on the correct proforma
- More than one response per stakeholder organisation
- Confidential information or other material that you would not wish to be made public
- Personal medical information about yourself or another person from which your or the person's identity could be ascertained
What will happen to your comments
The Quality Standards Programme Team and Topic Expert Group will review all eligible comments received at the end of the consultation and will refine the quality standard in light of this information.
NICE reserves the right to summarise and edit comments received during consultations, or not to publish them at all, where in the reasonable opinion of the Institute, the comments are voluminous, publication would be unlawful or publication would be otherwise inappropriate.
Acknowledgement of comments
You should receive an automated acknowledgement from the email box when you email your comments. If you do not receive this acknowledgement, please contact the quality standards coordinator to ensure your comments have been safely received by emailing lucy.spiller@nice.org.uk.
Comments received in the course of consultations carried out by the Institute are published in the interests of openness and transparency. The comments are published as a record of the submissions that the Institute has received, and are not endorsed by the Institute, its officers or advisory committees.
Endorsing NICE Quality Standards
If you would like your organisation to endorse the ovarian cancer quality standard please email QualityStandards@nice.org.uk to express an interest. NICE is proud to jointly badge quality standards to help to achieve maximum dissemination among relevant audiences.
Those who endorse quality standards must be:
- National patient, carer, voluntary, charity and non-governmental organisations that are run by, or directly reflect the perspectives of patients, service users, carers or client groups, and represent the interests of people whose care is covered by the quality standard in England.
- National organisations that represent the healthcare professionals who provide the services described in the quality standard in England.
- Statutory organisations (an organisation set up by government for a specific purpose) including Ofsted, NHS Institute for Innovation and Improvement, Health Protection Agency, National Screening Committee, Joint Committee on Vaccination and Immunisation, National Patient Safety Agency and Local Government Improvement and Development.
Email enquiries
If you have any queries please email qualitystandards@nice.org.uk.
This page was last updated: 24 May 2012
